Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience

World Journal of Surgery

Volumn 40, Issue 4, 2016, Pages 921-928

  Rosa, Fausto ^a,h   Marrelli, Daniele ^b   Morgagni, Paolo ^c   Cipollari, Chiara ^d   Vittimberga, Giovanni ^c   Framarini, Massimo ^c   Cozzaglio, Luca ^e   Pedrazzani, Corrado ^d   Berardi, Stefano ^f   Baiocchi, Gian Luca ^g   Roviello, Franco ^b   Portolani, Nazario ^g   De Manzoni, Giovanni ^d   Costamagna, Guido ^a   Doglietto, Giovanni Battista ^a   Pacelli, Fabio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

^h FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; FEMALE; GASTRECTOMY; HUMAN; ITALY; KAPLAN MEIER METHOD; KRUKENBERG TUMOR; METASTASIS RESECTION; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; OVARIECTOMY; PARENTERAL DRUG ADMINISTRATION; PATHOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; STOMACH NEOPLASMS; SURVIVAL RATE; THERMOTHERAPY; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; GASTRECTOMY; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; ITALY; KAPLAN-MEIER ESTIMATE; KRUKENBERG TUMOR; METASTASECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR BURDEN;

EID: 84959574435     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-015-3326-8     Document Type: Article

References (26)

1. Krukenberg FE (1896) Uber Das Fibrosarcoma ovarii mucocellulare (carcinomatodes). Arch Gynäkol 50:287-321
2. Schlagenhaufer F (1902) Ueber das metastatische ovarial-carcinom nach Krebs des Magens, Darmes, und anderer Bauchorgane. Monatschr F Geburtsh U Gynäckol 1:485-528
3. Wang J, Shi YK, Wu LY et al (2008) Prognostic factors for ovarian metastases from primary gastric cancer. Int J Gynecol Cancer 18:825-832
4. Kim HK, Heo DS, Bang YJ, Kim NK (2001) Prognostic factors of Krukenberg's tumor. Gynecol Oncol 82:105-109
5. Man M, Cazacu M, Oniu T (2007) Krukenberg tumors of gastric origin versus Krukenberg tumors of colorectal origin. Chirurgia (Bucur) 102(4):407-410
6. McGill F, Ritter DB, Rickard C et al (1998) Management of Krukenberg tumors: an 11-year experience and review of the literature. Prim Care Update Ob Gyns 5(4):157-158
7. Kiyokawa T, Young RH, Scully RE (2006) Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 30(3):277-299
8. Papakonstantinou E, Liapis A, Kairi-Vassilatou E et al (2011) Virilizing ovarian Krukenberg tumor in a 27-year-old pregnant woman. A case report and literature review. Eur J Gynaecol Oncol 32(3):331-333
9. Novak E, Gray LA (1938) Krukenberg tumors of the ovary. Clinical and pathological study of 21 cases. Surg Gynecol Obstet 66:157-167
10. Cheong JH, Hyung WJ, Chen J et al (2004) Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol 94:477-482
11. Cheong J, Hyung WJ, Chen J et al (2004) Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer. J Surg Oncol 87:39-45
12. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1:10-24
13. Sobin LH, Wittekind C, Gospodarowicz M (eds) (2009) TNM classification of malignant tumors (UICC), 7th edn. Wiley, New York, pp 73-77
14. Baiocchi GL, Marrelli D, Verlato G et al (2014) Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer. Ann Surg Oncol 21(6):2005-2011
15. Kim WY, Kim TJ, Kim SE et al (2010) The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries. Eur J Obstet Gynecol Reprod Biol 149(1):97-101
16. Yoo CH, Noh SH, Shin DW et al (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236-242
17. Kim NK, Kim HK, Park BJ et al (1999) Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma. Cancer 85:1490-1499
18. Al-Agha OM, Nicastri AD (2006) An in-depth look at Krukenberg tumor: an overview. Arch Pathol Lab Med 130(11):1725-1730
19. Lu LC, Shao YY, Hsu CH et al (2012) Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer. Anticancer Res 32:3397-3401
20. Mrad K, Morice P, Fabre A et al (2000) Krukenberg tumor: a clinico-pathological study of 15 cases. Ann Pathol 20:202-206
21. Savey L, Lasser P, Castaigne D et al (1996) Krukenberg tumors. Analysis of a series of 28 cases. J Chir (Paris) 133:427-431
22. Pacelli F, Cusumano G, Rosa F et al (2013) Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study (On behalf of the Italian Research Group for Gastric Cancer - IRGGC). JAMA Surg 148:353-360
23. Cho JH, Lim JY, Choi AR et al (2014) Comparison of surgery plus chemotherapy and palliative chemotherapy alone for advanced gastric cancer with krukenberg Tumor. Cancer Res Treat. doi: 10.4143/crt.2013.175
24. Preusser P, Wilke H, Achterrath W et al (1989) Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7:1310-1317
25. Di Giorgio A, Pinto E (eds) (2015) Treatment of peritoneal surface malignancies. State of the art and perspectives. Springer-Verlag XVI, Berlin
26. Yang XJ, Huang CQ, Suo T et al (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improve survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 34:1246-1252